INTERNA MEDICINA MANOJLOVIC PDF

June 25, 2020 0 Comments

U Interna Medicina. Manojlović D. Ed. Zavod. za udžbenike i nastavna U Fizikalna medicina i rehabilitacija. Jevtić M, Ed. Univerzitet u. In: Interna medicina. Manojlovic D. Ed. Zavod za udzbenike i nastavna sredstva Beograd, Beograd, 2. Autman ME, Braunvald. Vasiljevic-Pokrajcic Z. Ishemijska bolest srca. In: Interna medicina. Manojlovic D. Ed. Google Scholar. 3. Reiner. Ateroskleroza. In: Interna medicina.

Author: Taushura Akimuro
Country: South Africa
Language: English (Spanish)
Genre: Literature
Published (Last): 14 February 2015
Pages: 297
PDF File Size: 18.43 Mb
ePub File Size: 12.51 Mb
ISBN: 651-6-72507-578-2
Downloads: 92949
Price: Free* [*Free Regsitration Required]
Uploader: Sharisar

Ischemic heart disease IHD is a most common manifestation of generalised atherosclerosis. Hyperlipidemia is one of the most significant risk factors causing atherosclerosis.

Becouse of this, statin therapy is the guideline in therapy of hyperlipoproteinemia. The research included 74 patients with hyperlipoproteinemia type II and III, with 59 patients medicia without 15 coronary disease diagnosis.

All mabojlovic have mddicina treated with statins. In all patients, we analizing statins hypolipemic effects, and the research was carried out: Target value of lipoprotein profile parameter is achieved after months of statin treatment. According to the results HDL-cholesterol was changed with the statins for The statin therapy has significant effect on lipoprotein profile and atherogenic index. That effect is the most intensive after 3 month therapy, and target level of lipoprotein parameter are achieved after months of statin treatment.

  AECTP 230 PDF

Zavod za udzbenike i nastavna sredstva Beograd, Beograd, Autman ME, Braunvald E.

Can Statins Help „Good Cholesterol“ to Become Even Better

Acute myocardial infarction, In: Heart disease-A Textbook of cardiovascular Medicine. WB Saunders company, Philadelphia, Medicinska biblioteka, Zagreb, Drug therapy for hypercholesterolemia and dyslipidaemia. In The Pharmacological basis of therapeutics. Implications for the general practitioner. Curr Med Res Opin. Heart Protection Study Collaborative Group. A randomized placebo- inetrna trial.

Rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease. Agents mahojlovic in Hyperlipidemia. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering meidcina patients with coronary heart disease: V kongres Interne medicine-Zbornik radova, ; Klinicki ekspertski izvestaj-Sortis, Parke Davis, Beograd, Lipanor ciprofibrat u terapiji hiperlipoproteinemija.

Zorka Pharma, Beograd, Am J Manag Care. DP za izdavacko trgovinsku delatnost Beograd, Beograd, Symposiun Procedings-Identify the patients, achieve the goal- Improving current dyslipidaemia therapy. Efficacy and safety of simvastatin versus atorvastatin: Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and “normal” cholesterol levels.

A randomized, placebo-controlled trial. The reality of statin use in primary inrerna. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: Current medical research and opinion.

Can Statins Help „Good Cholesterol“ to Become Even Better : Macedonian Journal of Medical Sciences

Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia. Treating hyperlipidemia for the primary prevention of inteena disease. Are higher dosages of lovastatin cost-effective? Beyond the cholesterol profile: Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation.

  LOI 30-85 TVA MAROC PDF

Gemfibrozil decreases autoantibodies againts low density lipoprotein in men with combined hyperlipidaenia.

Statinfibrate combinations in patients with combined hyperlipedemia. Efficacy of rosuvastatin 10 mg in patients with Metabolic Syndrome.

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. User Account Sign in to save searches and organize your favorite content. De Gruyter – Sciendo.

Violeta Iric-Cupic smcard live. Issue 3 First Online: The aim of intwrna study was to show the hypolipemic effect of statins. Hyperlipidemia ; statins ; atherosclerosis. Sign in to annotate.